Taken together, these results strongly indicate that ABT-737 promotes cell apoptosis induced by erlotinib in EGFR-mutant NSCLC cells containing BIM deletion polymorphism. The gene discussed is BCL2L11; the disease is non-small cell lung carcinoma.